A Multi-Institutional, Prospective, Randomized, Double-blinded, Phase II Trial of the Tumor Lysate, Particle-Only (TLPO) Vaccine Compared to Tumor Lysate, Particle Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in High-risk Melanoma Patients-MedSci.cn

A Multi-Institutional, Prospective, Randomized, Double-blinded, Phase II Trial of the Tumor Lysate, Particle-Only (TLPO) Vaccine Compared to Tumor Lysate, Particle Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in High-risk Melanoma Patients

Chick, RC; Faries, MB; Hale, DF; Bohan, PK; Hickerson, AT; Vreeland, TJ; Myers, JW; Cindass, JL; Brown, TA; Hyngstrom, J; Berger, A; Jakub, JW; Sussman, JJ; Shaheen, MF; Clifton, GT; Wagner, TE; Peoples, GE

ANNALS OF SURGICAL ONCOLOGY, 2020; 27 (SUPPL 1): S133

科室
- - 订阅+
  - 更多科室
工具
服务